Antibiotic Development Incentives Face Critical Test As NDA Reviews Begin

Law has encouraged FDA to be flexible on data requirements for antibiotics, according to sponsors.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from United States

More from North America